Nasdaq: AMGN
Amgen Inc
$460.28▼ -3.80%Thursday, Nov 5 close · data delayed
Past 90 trading days
- 30-day change
- ▲ +10.95%
- 90-day high
- $478.48
- 90-day low
- $355.25
- Avg volume (20d)
- 2.8M
- Market cap
- $248.9B
- 52-week high
- $483.99
- 52-week low
- $253.30
Bellwize coverage
Stocks
Amgen Falls 10% After a Rival's Cholesterol Trial Misses Its GoalA failed late-stage study of a competing lipoprotein(a) drug from Novartis raised doubts about Amgen's own cholesterol program and drove one of its worst days in years.
Sep 9, 2026, 9:18 AM ET
Company resources
This is a general-market summary for information only — not investment advice, and not a recommendation regarding any security.